chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Discharge Provider:  MD Primary Care Provider at Discharge:  NP  Admission Date: 8/21/2022 Discharge Date: 8/29/2022  PRESENTING PROBLEM: Acute and chronic respiratory failure with hypoxia (HCC) [J96.21] COVID-19 [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: HPI: 79-year-old lady with medical history of hypertension, CKD stage 4, Morbid Obesity (BMI> 70), GERD, gastric bypass, depression and dementia presenting to hospital on 08/21 with cough, headaches, rhinorrhea.  Patient resides in a nursing home, states that she had headaches body aches and chills when she woke up in the morning.  She started having cough which was dry but then started producing yellowish sputum. No fever reported. A home COVID test was done which was positive.  She did not have any chest pain or tightness or discomfort.  No lightheadedness or dizziness.  She came to hospital where he was found to be tachycardic and hypoxic in mid 80's and was put on nasal cannula 2 L. CXR remarkable for Right lobe infiltrate/effusion.  She does have some memory deficits and unable to provide complete history.  She knows the children's name and where they are located. She would like her daughter be the DPOA. She would like to remain full code for resuscitation.      HOSPITAL COURSE: Patient treated with dexamethasone x 10 days,  She recieved 5 days of empiric abx for poss  bacterial pna (Rocephin/Azithromycin).  All cx were no growth to date.  Pt has now been weaned off supplemental oxygen, we will reassess prior to discharge.  Her vital signs have been stable.  Her creatinine is 2.09.  She will need close follow-up with this, of note her creatinine 1.7 in October 2001, 1.99 in February 2022. range in October 2021 Pt is stable for discharge.  Patient will need assistance at home.  I have discussed the case with her daughter.  Patient has been working with therapy and showing gains
3/24/08 had symptoms of fatigue, right sided facial paralysis.  Diagnosed with Bell's Palsy.
On 05/01/2021 around mid-afternoon, the right side of stomach began to swell and I was in discomfort. I didn't want to eat. I knew there was something wrong. The next day I was going to go to the ER but I thought I would wait. I Saw my primary Doctor on 05/03/2021 and he told me drive to the ER and not to stop. He had arranged for the ER doctor to see me right away. They took a CT scan and they confirmed I had appendicitis and 7 am the next morning  05/04/2021 they took it out laparoscopically. I had ten hours before it was going to burst. I was in the hospital for two days. After my Doctor looked at CT scan, they found cysts on my kidney's, not in kidneys but on and they are simple cysts and not malignant. That could have come from the vaccine in hindsight. It was multiple cysts. I have a f/u with urologist on 12/15/2021.
Warmth, erythema, induration 4 cm circle around injection site right thigh.
On 04/07 patient received pneumonia and flu shot in left arm IM. That same day, patient's arm swelled from site of injection to elbow turning red and skin warm.
A spontaneous report was received from a consumer who was a 59-years old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and who experienced the serious adverse event of cellulite at the injection site and local pain at the injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 31 Dec 2021, approximately one week prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number 039K20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   On 07 Jan 2021, the patient had local pain at the site of the injection.   On 08 Jan 2021, she visited a healthcare provided who diagnosed cellulite at the injection site. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, cellulite at the injection site and injection site pain, was not reported.; Reporter's Comments: This spontaneous report refers to a case of a 59-year-old female patient who experienced events of local pain at the site of the injection and event of cellulite at the injection site  8 days after the administration of the first and only dose of mRNA-127 (Lot number 039K20A, Exp date-unknown). Based on temporal the information provided and the absence of any other etiology factors, a causal association between both events and vaccine administration cannot be excluded.
Throat tightness with difficulty swallowing, tingling to face and head. Lasted approx 10-15 seconds.  Went to the emergency room and was stable at the time. Toward the latter part of the ER visit, I was given prednisone, Pepcid, and Benadryl. Have had no issues since then.
From faxed correspondence on 11/12/02, it was reported that an 8 year old female child received FLUZONE, lot # U0886AA, on 10/21/02. That same day, the patient developed a possible vesicular rash on top of ear. The patient recovered. No further information was provided from correspondence received on 4/14/03. This case is closed.
a little bit of a headache; cough; typical sore arm; This is a spontaneous report from a contactable consumer or other non hcp. A 54-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection) dose 1 via an unspecified route of administration on 29Jan2021 (Lot number and Expiry date was not reported) as single dose for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. On 29Jan2021, the patient experienced typical sore arm, on an unspecified date, experienced a little bit of a headache and cough. She thought that cough was the oddest thing. She does not have her CDC vaccine record card with her. Sore arm started on 29Jan2021, that evening she could feel it; by really feel it 30Jan2021 but it did not hinder her in any way shape or form. Cough onset date unknown other than in middle of the night, probably about midnight. She kept coughing and coughing; it was a very peculiar cough. She does not think she has ever had that kind of cough before. It was like a dry cough and she just kept coughing. Finally, she got up and she had those pearls, she was not sure of the name of the pearls; but she had some of those pearls and took that and went back to sleep. She got up and had a slight headache, a little bit of a headache nothing big but a peculiar headache; not one she has ever had before. She went and fed the homeless, she felt the sore arm but it did not hinder her in any way shape or form. She was getting ready for bed and the cough started again. She took the pearls again, went to sleep, no problem. She woke up and her arm was fine, no coughing. She recovered completely from all of these events with Pfizer COVID-19 Vaccine. She is scheduled to get the second dose of Pfizer COVID-19 Vaccine on 17Feb2021. She had been hearing the consensus that it seems like the second one was the booger so she was hoping to have as mild symptoms this time with second dose as the first. Pearls were just something she had that probably expired or might be from the beginning of the year before COVID; you know how in spring things start so she probably still had it from last year but the pearls worked fine, she had no problem. Pearls: Lot, NDC, Expiry were unknown, she does not have product with her. Therapeutic measures were taken with pearls for event cough. The outcome of typical sore arm was recovered on an unspecified date in 2021, and headache and cough were recovered.  Information on batch/lot number was requested.
Itchy rash around the site of the injection; Rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy rash around the site of the injection) and VACCINATION SITE RASH (Rash around the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy rash around the site of the injection) and VACCINATION SITE RASH (Rash around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy rash around the site of the injection) and VACCINATION SITE RASH (Rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment provided include anti-itch cream.
MINOR ALLERGIC REACTION... red eyes, patient c/o facial swelling Benadryl  PO 50mg/20ml administered. Pt. left alert and oriented
feeling of a "hot flash"; feels like she has "brain fog"; arm is sore; feels achy; headache; This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (feeling of a "hot flash"), MEMORY IMPAIRMENT (feels like she has "brain fog"), PAIN IN EXTREMITY (arm is sore), PAIN (feels achy) and HEADACHE (headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Allergies include codeine, clindamycin, sulfa drugs, hydrocodone, ciprofloxacin, and nitrofurantoin).    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced HOT FLUSH (feeling of a "hot flash"), MEMORY IMPAIRMENT (feels like she has "brain fog"), PAIN IN EXTREMITY (arm is sore), PAIN (feels achy) and HEADACHE (headache). At the time of the report, HOT FLUSH (feeling of a "hot flash"), MEMORY IMPAIRMENT (feels like she has "brain fog"), PAIN IN EXTREMITY (arm is sore), PAIN (feels achy) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Hallucinating; Urinary incontinence; Lack of awareness / became unaware and didn't know where he was; Lethargic; Couldn't find the bathroom; Couldn't get off the end of the couch; Temp of 102-103; A spontaneous report was received from a consumer concerning a 78-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced temperature of 102-103, urinary incontinence, lack of awareness, hallucinating, lethargic, couldn't find the bathroom and couldn't get off the end of the couch.   The patient's medical history was not provided. No concomitant medications were reported.  On 20 Jan 2021, before the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 21 Jan 2021, the patient developed temperature of 102-103 degree fahrenheit, urinary incontinence, lack of awareness, hallucinating, lethargic, couldn't find the bathroom and couldn't get off the end of the couch. The reporter stated that these side effects began approximately a day to two days prior to the vaccine. The treatment information included paracetamol.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome for the events, temperature of 102-103 degree fahrenheit, urinary incontinence, lack of awareness, hallucinating, lethargic, couldn't find the bathroom and couldn't get off the end of the couch were unknown.; Reporter's Comments: This report concerns a 78--year-old male who received Moderna's COVID-19 Vaccine (mRNA-1273), Lot # not provided, and experienced temperature of 102-103, urinary incontinence, lack of awareness, hallucinating, lethargic, couldn't find the bathroom and couldn't get off the end of the couch.  Very limited information regarding these events has been provided at this time.  Further information has been requested.
10:11 c/o SOB SaO2 98%, HR 98, Right arm injection site red/warm cold pack applied, Benadryl 25 mg po; 10:16 SaO2 97%, HR 98; 11:15 Pt verbalizes feeling "okay"; 11:25 SaO2 95% HR 72 sleeping easily aroused s/s resolved; 12:45 Released. MD Release Okay.
Vaccine was given subcutaneously, not intramuscularly. Pt prefer IM.
Client vaccinated at 9:30 am. At 4:00 pm c/o headache, vomiting, chest pain, racing heart, diaphoresis, fever (100.6). Mother took client to urgent care. Observed for 1/2 hr, given MOTRIN and sent home. Client has hx of Oppositional Defiance Disorder. ADHD. Nothing noted on consent form. No adverse symptoms on 12/1/11.
Dizziness, severe headache, heart palpitations, fever 102.5, blurred vision, severe earache, ringing in ears, pain behind eyes, vertigo, nausea, stomach pain on day of vaccine. Took ibuprofen 200mg. on  4/25 at 8:00 am. Fever and chills resolved and headache lessened with ibuprofen. Went to emergency room for dizziness and heart palpitations on 3/30. Heart palpitations resolved after hospital evaluation. Headache, vertigo, earache and ringing in ears persist to present
pt received first dose on left arm on 4/9/21 and had no side effects.  pt received second dose on right arm on 5/7/21 and had the following symptoms starting 3 days after the second dose.  symptoms were pain in both arms, including shoulders and hands that persisted until today (patient reported symptoms on 6/26/21) for over a month. Tylenol did not help with pain.  recommended pt to try voltaren gel for local pain where is worse, continue to monitor symptoms and f/u with pcp if no improvement or gets worse.
Patient lied about getting the J&J vaccine prior to getting the COVID-19 Pfizer vaccine. I asked him if he had received any other COVID-19 vaccine prior to today and he said no. After I gave him the Pfizer COVID vaccine, he then told me he got the J&J vaccine a while ago. I advised him that this is not what is recommended.
Staff was advised that patient had a brief episode of palpitaions "30 seconds" after receiving the COVID19 vaccine on 12/22/20 that resolved. Per report on back of  patient consent, vitals done  at 1513: BP 145/102, HR 84, O2 SAT 99%, RR 18, TEMP 97.6. Re-take at 15:21, BP 124/86, HR 86, O2SAT 100%, RR 18, TEMP 97.8. Patient was monitored for 30 minutes, Dr. was present at time of event.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with (Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the (Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccine administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 17-OCT-2014, the patient was vaccinated with a dose of (Merck) VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Patient is a 64 y.o. male patient of DO with history of stage IV Hodgkin lymphoma, HIV, bipolar depression, obstructive sleep apnea, GERD, chronic back pain, BPH, and hemorrhoids who presented to Hospital with weakness and diarrhea.  He was found to be covid positive on 3/17. Has been doing overall good and stable. Reached out to palliative for goals of care conversation. Patient notes he would like to be DNR CC and would like pain management with no medical management for his conditions. Hospice team has been following with patient, however, patient would like to go home for now. Discussed other options for hospice, as well as provided number for his oncology navigator who has been trying to get him established with hospice as well. At this time, stable for discharge and outpatient follow up.   Sepsis, resolved COVID 19 - 3/17 On presentation, hypertensive and tachypneic; leukopenic at 2.52; with lactic acidosis (2.4) COVID-positive Chest x-ray with possible bronchitis ED course - 30 cc/kg fluid bolus and IV Zosyn at this time Continue empiric IV Zosyn ID consulted. Appreciate input. Continue empiric antibiotics.   Palliative consulted for goals of care - Wants to focus on comfort care and is interested in utilizing support of hospice Referral to hospice placed.  Appreciate input from hospice as they formulate plan; patient requesting home hospice   Diarrhea, chronic, improved CT abdomen pelvis with mild central mesenteric edema and could indicate some form of mesenteric adenitis; as well as fluid in the proximal colon Blood cultures 1/2 with staph epi  Started on IV zosyn but discontinued after no bacterial etiology Continue IV fluids C. difficile negative Monitor   HIV infection DNR CC Last CD4 146 in December 2022 Patient was previously on Biktarvy, stopped treatment on his own Declines Biktarvy   Stage IV Hodgkin lymphoma DNR CC Diagnosed in June 2021 Underwent 5-6 cycles of chemotherapy, stopped treatment on his own WBC 2.52 CTPA with nonspecific mediastinal, right hilar, and periportal lymph nodes concerning for metastatic disease Pulmonary consulted during last admission 2 weeks ago as pt declined further therapy for his lymphoma and is not interested in further diagnostic evaluation.   Oncology consulted prior admission - Recommend PET CT scan outpatient if patient desires follow-up. Would need to follow-up back for surveillance and evaluate for recurrent disease. Palliative consulted as above.  CODE STATUS DNR CC
Pt came into clinic after shots for immigration.  She was given a Tdap and an MMR in left arm.  Six days later she came back to clinic with a bruised and swollen arm with a large red ring around it.  She was sent to see a doctor.
Narrative:  SLEPT ALL DAY  Other Relevant Hx: Symptoms:  & FATIGUE Treatment:
Dose 3, FM0648 - On 3/21/2022, I experienced full body cramping, headaches, nausea, vomiting, diarrhea, fever, chills, and swollen lymph node under left arm beginning 10 hours after injection and lasting until noon on 3/23/2022. I reported this adverse reaction to CNP at a HCF on 3/23/2022. I missed work entirely on 3/22/2022, and took one-hour sick leave on 3/23/2022.   Dose 2, FC3184 - On 9/13/2021, I experienced full body cramping, headaches, nausea, vomiting, diarrhea, fever, and chills beginning 10 hours after injection and lasting about 48 hours. I did not report this adverse reaction to any healthcare professional. I missed work entirely on 9/14/2021, and took four-hours sick leave on 9/15/2021.
SIDS; thymus gland petechial hemorrhages; cardiovascular system petechial hemorrhages resp system lungs mottled white & purple & w/petechial hemorrhages;
This case was reported by a consumer via call center representative and described the occurrence of fever in a 57-year-old male patient who received SHINGRIX for prophylaxis. On 10th July 2018, the patient received SHINGRIX (intramuscular). On 11th July 2018, 1 days after receiving SHINGRIX, the patient experienced fever, shivering and muscle pain. On an unknown date, the outcome of the fever and muscle pain were unchanged and the outcome of the shivering was unknown. The reporter considered the fever, shivering and muscle pain to be probably related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX vaccine on left deltoid. The patient woke up in the morning, on the day of reporting, with fever, aching muscles and shivering.
Screaming et leg swollen (L), malaise and upset for over 24 hours.
83-year-old male with history of multiple myeloma presented to the emergency department with respiratory distress. Per EMS and wife, patient was discharged from the hospital a few days prior, following an 8 day hospital admission. He was hospitalized due to difficulty breathing and was found to have "fluid in his lungs". Patient was discharged to a nursing home, where he has been for the last 3-4 days. Nursing home staff found him to be in respiratory distress and satting in the 60s on room air. EMS was called and placed him on 15L NRB with O2 sats in the 80s. They then placed him on CPAP which increased his O2 to 94. Patient was on BIPAP on arrival. Additionally, per family patient's right shoulder and arm have been swollen over the last 2 days. Patient was found to be COVID-19 positive. Patient was in acute hypoxic respiratory failure. Code status was changed and patient expired in hospice care.
Erythema Multiforme 12 days post Gardasil vaccine. Eruptions started on 10 day post vaccine
Chills; Fever; Vomiting all day; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting all day) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting all day). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Mar-2021, CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting all day) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2020, SARS-CoV-2 test: positive (Positive) positive. On 05-Mar-2021, Body temperature: 102 (High) 102 Fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.
Fever, chills, severe nausea, dehydration; required trip to ER to receive fluids and anti-nausea meds
2 days p/vax & to ER w/nausea/vomiting, body aches, dizziness, lt shoulder was edematous
I only had mild symptoms after getting the injection. The site was tender for about a day, then was fine. But about 5 days after getting the injection, the area around the injection site started to swell, got hot, and itch. And now there is a rash. The area is about 3-4 inches in diameter.  It's been going on for a couple of days and is very itchy even after applying topical steroid and taking Claritin.
Fever up to 102.6 and 26x28mm induration on right thigh.
Rash on chest area,  headache and muscle aches  Lasted 2 days.  Rash still on chest
Sharp chest pains while walking began suddenly on  9/15/2021  (seven days after vaccine).   Symptoms seem to improve but later worsened resulting in trip to emergency room on 1/30/2022 for extreme sharp chest pains.  Misdiagnosed and treated as GERD by emergency room physician and then by gastroenterologist on 2/10/2022. Became severe enough evening of 2/12/2022 to return to emergency room.   Heart attack while in emergency room.